When Weight Loss Outpaces the Skin: Redefining Body Contouring in GLP‑1 Patients
GLP‑1 receptor agonists — semaglutide, tirzepatide, and their peers — have fundamentally reshaped how we think about weight management. But as these medications move further into the mainstream, a new clinical reality is emerging: the scale changes faster than the skin. For aesthetic practitioners, this is both a challenge and a significant opportunity.
The GLP‑1 Revolution and Its Aesthetic Consequences
Medications such as Ozempic®, Wegovy®, and Mounjaro® have transformed metabolic health and made meaningful, sustained weight loss more accessible than at any point in history. Global prescriptions for GLP‑1 agonist therapies grew at approximately 38% annually between 2022 and 2024, with sales projected to reach $100 billion by 2030. That is not a niche patient population — it is a generation of new patients walking through your clinic doors.
As published research in the Journal of Cosmetic Dermatology has confirmed, rapid weight reduction induced by these medications frequently leads to aesthetic challenges, including facial volume loss, skin laxity, and body contour irregularities.
Why the Skin Struggles to Keep Up
Skin is a living, dynamic organ — but it has its limits. When fat volume decreases rapidly, the structural scaffolding that once supported the skin from beneath is removed faster than the dermis can remodel. Collagen and elastin fibres lose their ability to retract and rebound. The result: sagging, crepey texture, deflated contours, and — paradoxically — patients who have achieved significant metabolic success but feel aesthetically worse than before treatment.
Body areas most commonly affected include the arms, abdomen, inner thighs, and flanks, alongside the face and neck.
“Weight is just a number. Skin quality is what ultimately defines shape, curves, and long-term aesthetic success.”
Dr. Khanh Nguyen — Plastic Surgeon, Body Sculpting Specialist
Understanding Your GLP‑1 Patient: Three Clinical Profiles
Not all GLP‑1 patients are the same. Drawing from clinical experience shared at InMode’s Gran Canaria Summit, Dr. Khanh Nguyen outlined three broadly distinct patient profiles that practitioners are increasingly encountering. Recognising which profile sits in front of you is the first step toward a tailored and effective treatment plan.
Steady, measured weight loss. Skin has had some opportunity to adapt. Mild to moderate laxity. These patients often respond exceptionally well to RF-based skin tightening — the window for preventive treatment is open and should be taken advantage of early.
Repeated cycles of loss and regain place cumulative stress on skin architecture. Elastin is progressively damaged with each cycle. These patients present with more complex laxity patterns and may require combination approaches.
Significant, rapid fat reduction — sometimes exceeding 20–30% of body weight — leaves behind severely compromised skin. These cases require the most comprehensive planning, often combining energy-based tightening with surgical assessment.
Across all three profiles, one clinical principle holds constant: reducing volume without addressing skin quality leads to incomplete — and sometimes ageing — results. The paradigm must shift from fat removal to tissue management.
The Technology Answering the Challenge: InMode IgniteRF
InMode’s IgniteRF platform — exclusively available in South Africa through Stern Aesthetic Solutions — is a multi-modality workstation designed to treat the full spectrum of tissue laxity, from mild subdermal contraction to significant body-area remodelling, all within a single platform. At its core, the platform leverages two transformative RF technologies:
RFAL — BodyTite, FaceTite, AccuTite
Bipolar radiofrequency energy delivered between an internal cannula and an external electrode. Simultaneously liquefy residual fat and contract the overlying skin in a single pass. Clinical data demonstrates up to 35% soft tissue contraction over 12 months — results previously only achievable through excisional surgery.
QuantumRF 10 & 25 — Subdermal Precision
Fractionated bipolar RF energy delivered via a fine cannula to the subdermal plexus. Delivers precision pulsed energy in fractional zones, maximising collagen stimulation while minimising thermal spread. Results in pronounced tissue contraction and a visible “shrink-wrap” effect.
What IgniteRF Delivers for GLP‑1 Patients
- Addresses skin laxity and soft tissue deflation at the subdermal level
- Improves contour regularity in areas of irregular fat loss
- Stimulates new collagen and elastin for long-lasting structural improvement
- Reduces the need for aggressive excisional surgery in appropriate candidates
- Combines multiple modalities in a single treatment session
- Minimal downtime relative to surgical alternatives
- Real-time temperature monitoring for consistent, reproducible safety
A New Approach to Body Contouring Consultations
The arrival of GLP‑1 patients in your practice demands a rethinking of how initial consultations are structured. Traditionally, body contouring consultations centred on fat volume and measurements. Today, skin quality assessment must become the primary lens through which outcomes are planned.
When was the patient’s weight loss most rapid? Is it ongoing or stabilised? Has the patient experienced weight cycling? What is the current degree of laxity, and how does skin elasticity differ across treatment zones? These are the questions that determine which technology — and which sequence of treatments — will deliver the most satisfying result.
Supporting GLP‑1 Patients at STERN
As South Africa’s exclusive distributor of InMode technology — including the full IgniteRF platform — Stern Aesthetic Solutions brings more than equipment to your practice. With 27 years of experience supporting over 500 clinics nationwide, Stern provides the clinical training, ongoing support, and treatment planning guidance your team needs to achieve consistently outstanding outcomes with GLP‑1 patients.
The IgniteRF platform is available now. Whether you are looking to introduce a dedicated GLP‑1 body contouring offering, expand your existing treatment menu, or simply ensure your practice stays ahead of one of the most significant patient demographic shifts in recent aesthetic history, we are here to help you do it with confidence.